Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative liposomal bupivacaine PENG block for DVT prevention in elderly hip fracture patients
ChiCTR2500100799Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Apr 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in hip fracture, sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2500100799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100799.